test Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company. It is focused on proprietary technology platforms to develop safer prescription drugs. The firm's Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms, are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and...
Some of you have asked me for an XRP update.There's nothing new price action from what I've already published, but hey here's something for fun Ripple is a technology that acts as both a cryptocurrency and a digital payment network for financial transactions.
test Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal and associated products. It operates through the following segments: Helomics, Skyline, Soluble, and Corporate. The Helomics segment includes clinical testing and...
test Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the discovery and development of novel inhaled therapeutic products for respiratory and other diseases. The firm focuses on the prevention and treatment of respiratory diseases and infections. It offers products based on its proprietary dry powder delivery technology, iSPERSE, which...
test OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It also engages in the development of molecular information products and services for global healthcare settings. It also offers guidance to clinicians about life threatening infections, improve patient outcomes, and...
test $31.19 Gap Close Titan Pharmaceuticals, Inc. engages in development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, ProNeura. Its lead product is Probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction. The company was founded by Louis R. Bucalo in February 7, 1992...
test Remark Holdings, Inc., is a technology-focused company that develops and deploys artificial intelligence (AI) products and AI-based solutions for businesses in various industries. It operates through its Technology and Data Intelligence segment, which provides products and services based on collected and processed data by using KanKan, a data intelligence...
test InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a. Its products include IFX-1 and IFX-2. The company was founded by Niels Christoph Riedemann, Renfeng Guo and Nicolas Fulpius in December 2007 and is headquartered in Jena, Germany.
test Shiba Inu (ticker: SHIB), also known informally as Shiba Token, is a decentralized cryptocurrency created in August 2020 by an anonymous person or persons known as "Ryoshi". Shiba Inu is a Japanese term for a breed of dog; it is the dog that is depicted in Dogecoin's symbol, which itself was originally a joke cryptocurrency based on the Doge meme.
test Remark Holdings, Inc., is a technology-focused company that develops and deploys artificial intelligence (AI) products and AI-based solutions for businesses in various industries. It operates through its Technology and Data Intelligence segment, which provides products and services based on collected and processed data by using KanKan, a data intelligence...
test It's gone. Remark Holdings, Inc., is a technology-focused company that develops and deploys artificial intelligence (AI) products and AI-based solutions for businesses in various industries. It operates through its Technology and Data Intelligence segment, which provides products and services based on collected and processed data by using KanKan, a data...
test Benessere Capital Acquisition Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in September 2020 and is headquartered in Miami, FL.
test Cemtrex, Inc. engages in the provision of solutions in the technology. It operates through the following segments: Advanced Technologies and Industrial Services. The Advanced Technologies segment delivers cutting-edge technologies in the IoT, Wearables and Smart Devices, such as the SmartDesk. It also includes the Company's subsidiary Vicon Industries, which...
test Meten Holding Group Ltd. offers online English Language Training(ELT) and other English language-related services to students from a wide range of age groups. It operates through the following segments: General Adult English Training, Overseas Training Services, Online English Training, and Junior English Training. The General Adult English Training segment...
test Fangdd Network Group Ltd. is an investment holding company. Through its subsidiaries, it engages in the provision of real estate information services through its online platform. It also offers integrated marketing services for individual customers, real estate developers, and agents. The company was founded by Yi Duan, Xi Zeng, and Jian Cheng Li in October...
test Sio Gene Therapies Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. Its product pipeline focus on Parkinson's Disease, GM1 gangliosidosis, and GM2 gangliosidosis such as Tay-Sachs disease and Sandhoff disease. The company was founded on October...
test InMed Pharmaceuticals, Inc. engages in the provision of biopharmaceutical research and development of novel. It also involves in cannabinoid-based therapies and a biosynthesis system for the manufacturing of pharmaceutical-grade cannabinoids. The company was founded by Christopher Bogart, Sazzad Hossain, Hyder A. Khoja, and Craig D. Schneider on May 19, 1981...
test Sonnet BioTherapeutics Holdings, Inc. engages in the development of biologic drugs with enhanced single or bispecific mechanisms. Its technology utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. The company was founded in 2011 and is headquartered in Princeton, New Jersey.